Status:
RECRUITING
Understanding Ketamine's Dissociative Effects (KD Study)
Lead Sponsor:
Stanford University
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Detailed Description
The goal of this proposed research is to record the effects of ketamine on brain activity to understand the changes that occur during dissociation in epilepsy patients with stereoEEG.
Eligibility Criteria
Inclusion
- Patient in Stanford Epilepsy Monitoring Unit
- Age \>18 years old.
Exclusion
- Lifetime psychotic or bipolar disorder
- Inability to speak, read or understand English
- Pregnant or nursing females
- Prior adverse ketamine response
Key Trial Info
Start Date :
July 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04861051
Start Date
July 26 2021
End Date
August 1 2028
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Palo Alto, California, United States, 94305